Aptose Biosciences Inc. (TSX:APS)
Canada flag Canada · Delayed Price · Currency is CAD
2.400
0.00 (0.00%)
Inactive · Last trade price on Jul 3, 2026

Aptose Biosciences Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
65202772154
Market Cap Growth
2.13%-72.33%-26.49%-63.04%-53.23%-69.01%
Enterprise Value
5131234-435
Last Close Price
2.402.129.75100.50351.00778.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
-0.13-0.14-2.99-6.941.411.64
P/TBV Ratio
----1.411.64

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.95-1.00-2.34-0.350.040.01
Net Debt / Equity Ratio
-0.92-0.97-0.982.84-1.21-1.06
Net Debt / EBITDA Ratio
-1.21-1.06-0.170.161.081.20
Net Debt / FCF Ratio
-1.27-1.19-0.120.191.411.81
Quick Ratio
0.090.101.380.613.829.68
Current Ratio
0.550.692.140.784.0310.00
Return on Equity (ROE)
----293.95%-74.70%-67.67%
Return on Assets (ROA)
-181.72%-153.45%-141.99%-102.23%-39.87%-39.18%
Return on Capital Employed (ROCE)
5124.80%-3501.80%-463.20%2296.30%-110.00%-88.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-627.97%-645.33%-187.07%-254.17%-78.63%-53.73%
FCF Yield
--557.20%-264.70%-221.47%-60.81%-35.77%
Buyback Yield / Dilution
-127.80%-250.13%-210.44%-9.81%-3.57%-8.86%